PUBLIC COMPANY
save$PDSBPDS Biotechnology Corp
$PDSB0.2089+4.09%Princeton, NJ, USupdated 9h ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
🐶 Hiring Signal
News
- PDS halts work on phase 3 cancer therapy to focus on colorectal contenderPDS Biotechnology has called a halt to its phase 3 head and neck cancer therapy to channel resources to a drug in phase 2 development for metastatic colorectal cancer.fiercebiotech · 7d ago
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that